Practice Makes Good: FDA, EMA Focus On CROs As GCP Info Sharing Improves
Executive Summary
FDA and EMA need more time working together before they can rely on each other’s Good Clinical Practice inspection findings, a recent joint report concludes.
You may also be interested in...
FDA/EMA Bioequivalence Collaboration Is Narrow In Scope, Wide In Reach
In contrast to the existing inspection program for clinical trials, sites around the globe will be targeted.
GMP Oversight Collaboration Helps FDA Plan, But Not Avoid, Foreign Inspections
FDA has improved planning efforts with information borrowed from European and Australian authorities, but an inspection collaboration between the three countries could not help it avoid some inspections.
GMP Oversight Collaboration Helps FDA Plan, But Not Avoid, Foreign Inspections
FDA has improved planning efforts with information borrowed from European and Australian authorities, but an inspection collaboration between the three countries could not help it avoid some inspections.